Yarman, S. Et Al. 2016. Double benefit of long-acting somatostatin analogs in a patient with coexistence of acromegaly and ulcerative colitis. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , no.5 , 559-562.

Yarman, S., Yalin, G. Y., Dogansen, S. C., Canbaz, B., Tanrikulu, S., & Akyuz, F., (2016). Double benefit of long-acting somatostatin analogs in a patient with coexistence of acromegaly and ulcerative colitis. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , no.5, 559-562.

Yarman, Emine Et Al. "Double benefit of long-acting somatostatin analogs in a patient with coexistence of acromegaly and ulcerative colitis," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , no.5, 559-562, 2016

Yarman, Emine S. Et Al. "Double benefit of long-acting somatostatin analogs in a patient with coexistence of acromegaly and ulcerative colitis." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , no.5, pp.559-562, 2016

Yarman, S. Et Al. (2016) . "Double benefit of long-acting somatostatin analogs in a patient with coexistence of acromegaly and ulcerative colitis." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , no.5, pp.559-562.

@article{article, author={Emine Sema YARMAN Et Al. }, title={Double benefit of long-acting somatostatin analogs in a patient with coexistence of acromegaly and ulcerative colitis}, journal={JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS}, year=2016, pages={559-562} }